Turn Therapeutics Inc. Furnishes Press Release in 8-K (Sept 9, 2026)

What Happened
Turn Therapeutics Inc. (TTRX) filed a Current Report on Form 8-K on September 9, 2026, reporting a Regulation FD disclosure and furnishing a press release. The press release is included as Exhibit 99.1 to the 8-K. The filing also references the required exhibits and the Inline XBRL cover page file.

Key Details

• Filing date: September 9, 2026 (Form 8-K).
• Item reported: 7.01 (Regulation FD Disclosure) — a press release was issued and furnished.
• Exhibit included: Exhibit 99.1 (Press Release dated September 9, 2026).
• Administrative exhibit: 104 (Cover Page Interactive Data File embedded in Inline XBRL).

Why It Matters
This 8-K notifies investors that Turn Therapeutics publicly released information on Sept 9, 2026; under Regulation FD the company made that information broadly available rather than sharing it privately. The 8-K itself does not present financial statements, earnings figures, executive changes, or deal-related disclosures — investors should read Exhibit 99.1 (the press release) or the company’s EDGAR filing to see any material updates (e.g., results, guidance, or management comments).